IGF2BP3 and neoplasm: For example, in an IHC study of 138 invasive ductal carcinomas of the breast, tumors that were histologically high-grade, exhibited tumor necrosis, or were of the TNBC subtype showed significantly increased IGF2BP3 expression, and IGF2BP3 expression was associated with poor patient prognosis (10).